Kanes Stephen

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

SAGE Therapeutics Inc (SAGE)

Transaction date 8 Feb 2019

Planned sale

Price

309.36

Quantity 51,445 -34.5%

Value US$414,097

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2019-02-08	2019-02-08	SAGE Therapeutics Inc (SAGE)	PlS Planned sale	51,445 -34.5% 309.36 US$414,097	51,445 -34.5%	309.36	US$414,097